Key result
A second nonrandom translocation, der(16)t(1;16)(q21;q13), was identified in 2 of 20 cases of Ewing sarcoma and 2 of 7 cases of peripheral neuroectodermal tumor, all also containing t(11;22).
Observational (n=27)
Identifies a second nonrandom translocation in Ewing sarcoma and PNET, providing a new target for investigating the molecular pathogenesis of these tumors.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in rare sarcomas; leaves open diagnostic or prognostic utility pending larger validation.
The majority of Ewing sarcomas and peripheral neuroectodermal tumors (PNET) that have been karyotyped contain a specific translocation, t(11;22)(q23;q11). We report here a second nonrandom translocation, der(16)t(1;16)(q21;q13), in 2 of 20 cases of Ewing sarcoma (seven previously unreported) and 2 of 7 cases of PNET (all previously unreported). All cases with this translocation also contained the t(11;22). Comparison of C-banding patterns in tumor and peripheral lymphocyte karyotypes in one case indicated that the likely breakpoints were 1q21 and 16q13. The presence of this translocation in cell lines will enable further investigation of the molecular events important in the pathogenesis of Ewing sarcoma and PNET.
No takes yet. Share an insight, caveat, or question.
Douglass et al. (2008) conducted an observational in Ewing sarcoma and peripheral neuroectodermal tumor (PNET) (n=27). der(16)t(1;16)(q21;q13) translocation was evaluated on Presence of der(16)t(1;16)(q21;q13) translocation. A second nonrandom translocation, der(16)t(1;16)(q21;q13), was identified in 2 of 20 cases of Ewing sarcoma and 2 of 7 cases of peripheral neuroectodermal tumor, all also containing t(11;22).
Synapse has enriched 10 related papers. Consider them for comparative context: